Physician profile
Frederic Chi
NPI 1700828555
$3,433.54
in general payments reported to CMS, 2019-2025
10 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $327 · 2021: $12.37 · 2022: $1,506 · 2023: $539 · 2024: $105 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $951.05 | 2019-2023 | Ozark Cervical Plate System, Serrato |
| Zimmer Biomet Holdings, INC. | $852.77 | 2019-2022 | |
| Linvatec Corporation | $603.80 | 2019-2023 | Biobrace 23mm |
| Vericel Corporation | $408.26 | 2025 | Maci |
| Smith+Nephew, INC. | $157.27 | 2019-2021 | |
| Arthrex, INC. | $156.80 | 2020 | |
| Orthalign INC | $125.00 | 2020 | |
| Heron Therapeutics, INC. | $89.42 | 2024 | Zynrelef |
| Depuy Synthes Sales INC. | $73.27 | 2019 | |
| Bioventus LLC | $15.90 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederic Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.